Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)
Clinical trial NCT01635790 · UNKNOWN
Trial details
- NCT number
- NCT01635790
- Sponsor
- Prof. dr. R.O. Schlingemann
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2016-06-01
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.